易明医药最新股东户数环比下降14.94%

Group 1 - The core point of the article highlights that Yiming Pharmaceutical has seen a significant decrease in the number of shareholders, with a reduction of 3,379 accounts, representing a 14.94% decline compared to the previous period [2] - As of the latest report, Yiming Pharmaceutical's closing price was 22.31 yuan, reflecting a 3.00% decrease, although the stock price has increased by 2.81% since the concentration of shares began [2] - The company's Q1 financial report indicates a total revenue of 149 million yuan, a year-on-year decrease of 7.41%, and a net profit of 18.79 million yuan, down 32.64% year-on-year, with basic earnings per share at 0.1000 yuan and a weighted average return on equity of 2.51% [2]